Who Paid My Doc
GORE CARDIOFORM Septal Occluder
Device Devices
PDI 00733132631018
General payments
$2,395,726
Research payments
$1,128,665
Through program year 2025, $2,395,726 in general payments and $1,128,665 in research payments were reported against GORE CARDIOFORM Septal Occluder (Devices).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $431,889 | 1,858 |
| 2025 | Research | $795,662 | 220 |
| 2024 | General | $469,772 | 1,861 |
| 2024 | Research | $310,008 | 88 |
| 2023 | General | $436,586 | 2,058 |
| 2022 | General | $630,219 | 2,998 |
| 2021 | General | $427,259 | 1,988 |
| 2021 | Research | $22,996 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 55 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
10,763 general · 309 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.